The Benefits

The Outcomes

  • A liquid suspension applicable to circa 70% of all drugs.
  • Proven examples include suspension of ibuprofen, paracetamol and asprin (circa 20-30% concentration).
  • Low viscosity mixture. Easier to drink.
  • The technology is reproducible and very stable.
  • It requires little processing other than blending and potentially mild heating.

Dysphagia Patient & NHS Benefits

  • Adherence to medicine plan.
  • Improved patient safety in reducing need for dysphagia patients to crush tablets.
  • Reduction in length of stay in hospital of between 2 and 8 days.
  • Increased inclusivity. Non-alcohol based. Open liquid medicines to patients practicing alcohol abstinence, for example, on religious grounds.